Cytochrome P450 monooxygenases (P450s) are a supergene family of enzymes involved in the biotransformation of a wide range of both endogenous and exogenous compounds. P450s play important roles in the metabolism of many drugs and in the activation of a variety of chemical toxicants and carcinogens in both humans and animals (1, 2) . High levels of P450s exist principally in the liver (1) , and studies using immunohistochemical techniques (3) (4) (5) (6) and in situ hybridization (7) have demonstrated differences in the regional distribution and region-specific induction of several P450s within the liver.
Constitutive activities and inducibility of different P450 isozymes are important in dictating species and individual differences in susceptibility to toxicants. The ability to assess gene expression and resulting enzyme activity without tissue disruption on an individual cell basis would further our ability to identify linkages between P450 expression and the zonal distribution of hepatic lesions caused by different toxicants. Recently, we reported on the use of alkoxyresorufin homologues in combination with noninvasive scanning laser cytometry as a method for directly determining CYPlAl functional activity in hepatoma cell lines (8) . In the present study, we used precision-cut, viable rat liver slices and confocal laser cytometry to determine the regional activities of P450 isozymes in situ.
A slice perfusion chamber that mounts on the cytometer stage was developed to allow for successive measurement of region-specific, P450-dependent 0-dealkylation of 7-ethoxy-, 7-pentoxy-, and 7-benzyloxyresorufin (EROD, PROD, and BROD activity, respectively) in the same liver slice. EROD activity in rat liver has been shown to be specific to CYPIA isozymes and is inducible by ,-naphthoflavone (,NF) and other polycyclic aromatic hydrocarbon-type inducing agents (8, 9) . BROD and PROD activities have been shown to be specific to CYP2B and CYP3A isozymes and are inducible by phenobarbital (9, 10) . The perfusion system ensures a constant concentration of substrate and limits the extracellular accumulation of the fluorescent product, resorufin (9) . In addition, the slice perfusion chamber allows for residual substrate and product to be washed away between successive perfusion assays. Materials (11) . The first and last slices containing the liver capsule were discarded. Liver slices were then placed in DOC vials (2 slices/vial) containing 2 ml of WEM as described by Smith et al. (12) . Slices were allowed to preincubate for at least 2 hr before use in subsequent perfusion assays or DOC EROD assays.
Slice perfusion. The slice perfusion apparatus shown in Figure 1 was used to successively measure region-specific EROD, PROD, and BROD activities in precision-cut liver slices. A plasma clot similar to that described by Gahwiler (13) alkoxyresorufin O-dealkylase activities in hepatic subcellular fractions and hepatocyte homogenates (16) . We used 25 pM dicumarol in our assays with liver slices, as this concentration was previously found to be optimal for measuring CYPlAl functional activity in hepatoma cell lines by scanning laser cytometry (8) . Sulfate anion was omitted from the reaction buffer to minimize conjugation via sulfation (17), as previously described (8) .
We determined region-specific EROD, BROD, and PROD activities by adding the appropriate alkoxyresorufin substrate to the perfusion buffer to a final concentration of 5 piM. EBSS without substrate was used to remove residual substrate and product between successive perfusions. Slices were washed with EBSS until fluorescence returned to baseline levels and was monitored by continuously scanning the liver slice.
Laser cytometry. Alkoxyresorufin 0-dealkylase activity was assessed directly in liver slices using an ACAS (adherent cell analysis and sorting) Ultima Laser Cytometer (Meridian Instruments, Okemos, Michigan) equipped with an argon ion laser and image analysis software. Initial focusing was carried out by examining the slice with normal transmitted light using a lOx objective. The same objective was used for laser illumination of the slice in confocal mode (pinhole setting of 100 pm). Maximum fluorescence response occurred within the first two to three cell layers from the surface of the slice and could be optimized by scanning in the Z. direction upon addition of substrate. Fluorescence due to resorufin formation was monitored using an excitation wavelength of 514 nm and an emission wavelength of >570 nm (using a long-pass dichroic filter). The photomultiplier tube voltage was held constant and data were collected using the kinetics software package supplied with the instrument. Data were analyzed on a DASY 9000 workstation (Meridian Instruments). EROD, BROD, and PROD activities were measured as increases in fluorescence intensity (arbitrary scale) within user-defined polygon regions of the liver slice exhibiting maximum EROD activity. Representative fluorescence pseudocolor images were saved as tagged image file format (TIFF) files and imported into a MacIntosh IIci personal computer. These images were then printed using PowerPoint software (Microsoft Corp., Redmond, Washington) and a Tektronix Phaser II SDX dye sublimation printer (Tektronix Corp., Beaverton, Oregon).
In vitro assays. We measured EROD activity in liver slices isolated from control and ,NF-treated rats in DOC as follows. Slices were preincubated for 2 hr in WEM as described above. Slices were then rinsed with EBSS, then incubated in 2 ml EBSS containing 5 pM ethoxyresorufin (ER) and 25 pM dicumarol. After the specified incubation time, the concentration of fluorescent resorufin product in the culture medium was determined by fluorescence spectrometry. We determined resorufin concentrations by comparing fluorescence intensity with a standard curve prepared from resorufin standards. All fluorescence measurements were made on a Perkin-Elmer LS-50 Luminescence Spectrofluorometer (Beaconsfield, UK) using an excitation wavelength of 530 nm and an emission wavelength of 580 nm.
Liver microsome samples were prepared by standard procedures. Microsomal protein concentrations were determined by the bicinchoninic acid method described by Smith et al. (18) . Microsomal (alkoxyresorufin-O-dealkylase activity assays were performed essentially as described by Burke and Mayer (19) preincubated slices were compared, the differences were not significant (p = 0.05).
The fluorescence images in Figure 2 were collected over a period of minutes in a typical experiment in which liver slices isolated from control and PNF-treated rats were perfused on the laser cytometer stage with EBSS containing 5 pM ER. Areas of increased fluorescence are due to the formation of the fluorescent resorufin product and are indicative of high EROD activity. Whole-slice scans (data not shown) revealed a heterogeneous pattern of EROD activity, suggesting differential induction of CYP IAl activity across regions of the liver lobule. The time elapsed during whole-slice scans made it impractical for kinetic analyses of entire slices, as fluorescence intensity increased substantially during the time required to stage-scan an entire slice (10 mm x 10 mm). Based on these kinetic considerations, we chose to scan smaller fields (1 mm x 1 mm, requiring <30 sec/scan using the fast-scanning mirror option on the ACAS). These fields contained vascular structures that appeared to be central veins. These structures were visible by light microscopy and could be targeted during initial focusing by manually positioning the slice with the computer-controlled X,Y stage. Areas of the slice where vascular structures appeared to be circular, indicating they were cut perpendicular to the slice surface, were suitable fields for resolution of the liver lobule. The size of the areas scanned by confocal laser cytometry roughly corresponds to the size of areas of distinct zonal immunocytochemical staining of CYPlAI shown in the photomicrograph of the liver section isolated from a ,BNF-pretreated rat (Fig. 3) .
The fluorescence images in Figure 2 show areas of intense fluorescence response in a liver slice isolated from a fNF-treated rat. The fluorescence level attained after 1275 sec of scanning in these areas is approximately 600-800 fluorescence intensity uniis (FIU), which is at least twofold higher than that observed in less-intense adjacent areas. Immunocytochemical data showing high levels of CYPlAI in centrilobular areas suggest that these images depict high EROD activity in centrilobular regions of the liver slice containing what appear to be small central veins.
Perfusion of control rat liver slices with ER resulted in a low fluorescence response and reflects the relatively low EROD activity in uninduced rat liver (9, 10, 16, 24) . The control rat liver section in Figure 3 slices have low, constitutive levels of EROD, BROD, and PROD activity, as has been shown previously in microsomes from untreated rats (9, 24) . In contrast to the equivalent response of control slices toward ER, BR, and PR, slices isolated from ,NF-treated rats show a highly differentiated response toward these three substrates. Figure 4 shows the increase in fluorescence intensity of seven defined areas containing cells and/or groups of cells exhibiting maximum fluorescence response. The relative maximum fluorescence response of liver slices from OiNF-treated rats toward ER is approximately 20-fold higher than the response toward BR and PR. The maximum rate of increase in fluorescence intensity over an approximate 3-min time period for each of the substrates in 3NF-treated slices was 307, 18.5, and 16.1 FIU/min for ER, BR, and PR, respectively. These results indicate that liver slices from ,NF-treated rats have high EROD activity relative to BROD and PROD activity and that EROD, BROD, and PROD activities are at least 30-, 1.8-, and 1.6-fold greater, respectively, in ,NFtreated slices than in control slices.
To ensure that the lack of fluorescence response of liver slices from ,NF-treated rats perfused with BR and PR was not due to possible depletion of cofactors resulting from the preceding ER perfusion, we reperfused slices with ER following BR and PR perfusion. The fluorescence response of the liver slice during the second ER perfusion approached the fluorescence response observed during the initial perfusion (Fig.  4) . The maximum rate of increase in fluorescence intensity for the second ER perfu- Figure 4 are more likely due to low substrate-specific isozyme expression rather than depletion of cofactors. Figure 5 shows the regression lines for the amount of the fluorescent resorufin product formed over time by liver slices isolated from both control and ONF-treated rats incubated with 5 pM ER in DOC. The correlation coefficient for the regression line that describes the rate of resorufin formation (EROD activity) in ,NFinduced liver slices indicates a high degree of linearity (R2 = 0.949). This suggests, as does the second ER perfusion in Figure 4 , that cofactors supporting 0-dealkylase activity are adequately maintained in liver slices from ONF-treated rats for periods of at least 60 min. In addition, the slope of the PINF-treated regression line is nearly 60-fold greater than the slope of the control regression line. Figure 6 further demonstrates the selective induction of EROD activity by ONF, as previously shown in whole-liver slice perfusion experiments (Fig. 4) . Microsomes isolated from ,BNF-treated rats had greater than 20-fold higher EROD activity than control rat liver microsomes. This is consistent with previous studies that compare microsomal EROD activity in control and PNF-treated rats (9, 24) . It is interesting to note, however, that the profile of 0-dealkylase activities in microsomes does not parallel the activity profile seen in wholeliver slice perfusion experiments. The activity profile for liver slices isolated from 3NF-treated rats could be described as EROD>>>BROD=PROD, whereas in microsomes from PNF-treated rats, the activity profile is EROD>BROD>> PROD. These differences may be due to the intact nature of the liver slice and may reflect differences in isozyme kinetics as a result of the more biologically relevant cofactor and substrate concentrations achieved in whole-cell systems.
Discussion
The fluorescence images in Figure 2 show (4, 26) . In addition, Buhler et al. (4) noted that the inducible forms of P450 they studied (2B1/2, 2E1, and 3A1) were generally induced in hepatocytes of the same zonal origin in which they were constitutively expressed. These findings led them to suggest that phenotypic differences exist between centrilobular and periportal hepatocytes with respect to factors that control P450 expression, causing hepatocytes of different zonal origins to respond differently to exogenous and endogenous signals.
Comparative studies investigating the phenobarbital responsiveness of rat hepatic hyperplastic nodules (HHN) have provided further evidence for phenotypic differences between centrilobular and periportal hepatocytes in factors that control P450 isozyme expression. Phenobarbital induces CYP3A1 in centrilobular hepatocytes (23) and CYP2B1/2 in centrilobular and midzonal hepatocytes (23, 27 (8, 31) . The ability of scanning laser cytometry to measure functional activity in a whole-cell system led us to hypothesize that laser cytometry could be used to measure functional P450 isozyme activity in viable precisioncut liver slices and that, because the architecture of the liver lobule in liver slices remains intact, marked differences in regional activity could be observed.
In conclusion, using a well-characterized induction protocol and P450 isozymespecific alkoxyresorufin substrates, we were able to show that confocal laser cytometry of precision-cut liver slices can be used to assess P450 isozyme-specific induction in intact liver tissue. More importantly, the method allows for the analysis of regionspecific induction of P450 activities, which are difficult to determine by conventional methods. These techniques should allow for the accurate quantification of P450 enzyme activity in situ and, with subsequent analysis of the same slice after fixation and processing, the ability to correlate specific P450 isozyme mRNA, specific P450 isozyme protein content, or other factors, with enzyme activity on an individual cell basis. These techniques should also be amenable to examination of similar phenomena in other tissues such as lung and kidney, where heterogeneity in cellular P450 expression is also known to occur.
